Literature DB >> 3537118

Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.

R Swanepoel, J K Struthers, M J Erasmus, S P Shepherd, G M McGillivray, B J Erasmus, B J Barnard.   

Abstract

Nine serological techniques were compared by monitoring the response to infection with Rift Valley fever (RVF) virus in three sheep. Antibodies were monitored daily for the first 14 days after infection, then weekly and later fortnightly up to week 24. The earliest antibody response was detected in one sheep on day 3 by a plaque reduction neutralization test, and by day 6 antibodies were demonstrable in all three sheep by haemagglutination-inhibition, reversed passive haemagglutination-inhibition, immunodiffusion, indirect immunofluorescence (IF), enzyme-linked immunosorbent assay and neutralization of cytopathic effect in cell cultures. Antibodies were demonstrable by complement fixation on day 8 at the earliest. IF and the two neutralization techniques produced the highest titres, but all tests could be used satisfactorily for the serological diagnosis of RVF. Inactivated antigen could be used for all except the neutralization tests. A radioimmunoassay technique using 125I-labelled staphylococcal protein A detected antibodies on day 8 at the earliest and produced lower mean titres than some of the other techniques. This was probably because sheep immunoglobulins bind protein A poorly.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537118      PMCID: PMC2083537          DOI: 10.1017/s0022172400065414

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  23 in total

1.  Observations on the epidemiology of Rift Valley fever in Kenya.

Authors:  F G Davies
Journal:  J Hyg (Lond)       Date:  1975-10

2.  Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.

Authors:  J A Zaia; M N Oxman
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

3.  Studies on the epidemiology of Rift Valley Fever.

Authors:  R Swanepoel
Journal:  J S Afr Vet Assoc       Date:  1976-06       Impact factor: 1.474

4.  The preparation of arbovirus hemagglutinins by sonication and trypsin treatment.

Authors:  P Ardoin; D H Clarke; C Hannoun
Journal:  Am J Trop Med Hyg       Date:  1969-07       Impact factor: 2.345

5.  Rapid diagnosis of arboviral and similar infections of man: Rift Valley fever in Egypt, 1977.

Authors:  J Casals
Journal:  J Egypt Public Health Assoc       Date:  1978

6.  Antibodies to Rift Valley fever virus in Swedish U.N. soldiers in Egypt and the Sinai.

Authors:  B Niklasson; J M Meegan; E Bengtsson
Journal:  Scand J Infect Dis       Date:  1979

7.  Rift Valley fever: an historical perspective.

Authors:  H Hoogstraal
Journal:  J Egypt Public Health Assoc       Date:  1978

8.  A rapid radioimmunoassay using 125I-labeled staphylococcal protein A for antibody to varicella-zoster virus.

Authors:  D D Richman; P H Cleveland; M N Oxman; J A Zaia
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

9.  An epidemic of Rift Valley fever in Egypt. 1. Diagnosis of Rift Valley fever in man.

Authors:  I Z Imam; M A Darwish; R El-Karamany
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

10.  Studies on Rift Valley fever in some African murids (Rodentia: Muridae).

Authors:  R Swanepoel; N K Blackburn; S Efstratiou; J B Condy
Journal:  J Hyg (Lond)       Date:  1978-04
View more
  26 in total

Review 1.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

2.  Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies.

Authors:  T G Besselaar; N K Blackburn
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Authors:  Bonto Faburay; William Wilson; D Scott McVey; Barbara S Drolet; Hana Weingartl; Daniel Madden; Alan Young; Wenjun Ma; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-20       Impact factor: 2.133

4.  Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.

Authors:  Bonto Faburay; William C Wilson; Arss Secka; Barbara Drolet; D Scott McVey; Juergen A Richt
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

Review 5.  Aptamers isolated against mosquito-borne pathogens.

Authors:  Tholasi Nadhan Navien; Tzi Shien Yeoh; Andrew Anna; Thean-Hock Tang; Marimuthu Citartan
Journal:  World J Microbiol Biotechnol       Date:  2021-07-09       Impact factor: 3.312

6.  Characterization of Palyam serogroup orbiviruses isolated in South Africa and serologic evidence for their widespread distribution in the country.

Authors:  T Whistler; R Swanepoel; B J Erasmus
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

7.  Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife.

Authors:  A Evans; F Gakuya; J T Paweska; M Rostal; L Akoolo; P J Van Vuren; T Manyibe; J M Macharia; T G Ksiazek; D R Feikin; R F Breiman; M Kariuki Njenga
Journal:  Epidemiol Infect       Date:  2007-11-08       Impact factor: 2.451

8.  Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; A J Shepherd; D E Hummitzsch; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

9.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

10.  Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa.

Authors:  Marietjie Venter; Stacey Human; Dewald Zaayman; Gertruida H Gerdes; June Williams; Johan Steyl; Patricia A Leman; Janusz Tadeusz Paweska; Hildegard Setzkorn; Gavin Rous; Sue Murray; Rissa Parker; Cynthia Donnellan; Robert Swanepoel
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.